|
|||||
|
|
Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer |
|
| Authors: | Douglas J. Robertson Jeffrey K. Lee C. Richard Boland Jason A. Dominitz Francis M. Giardiello David A. Johnson Tonya Kaltenbach David Lieberman Theodore R. Levin Douglas K. Rex |
| Affiliation: | 1. VA Medical Center, White River Junction, Vermont;2. Geisel School of Medicine at Dartmouth, Hanover, New Hampshire;3. University of California, San Francisco Medical Center, San Francisco, California;4. Baylor University Medical Center, Dallas, Texas;5. VA Puget Sound Health Care System, University of Washington School of Medicine, Seattle, Washington;6. Johns Hopkins University School of Medicine, Baltimore, Maryland;7. Eastern VA Medical School, Norfolk, Virginia;8. San Francisco Veterans Affairs Medical Center, University of California, San Francisco, California;9. Oregon Health and Science University, Portland, Oregon;10. Kaiser Permanente Medical Center, Walnut Creek, California;11. Indiana University School of Medicine, Indianapolis, Indiana |
| Abstract: | |
| Keywords: | CCE colon capsule endoscopy CI confidence interval CRC colorectal cancer DRE digital rectal examination FDA Food and Drug Administration FIT fecal immunochemical test FS flexible sigmoidoscopy gFOBT guaiac-based fecal occult blood test GRADE Grading of Recommendations Assessment, Development and Evaluation hgb hemoglobin OR odds ratio PPV positive predictive value RCT randomized controlled trial RR relative risk USMSTF United States Multi-Society Task Force |
| 本文献已被 ScienceDirect 等数据库收录！ | |